批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期 | 提交号 | 审批结论 | 申请内容分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
2020/08/18 |
SUPPL-11(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/04/08 |
SUPPL-7(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2015/03/26 |
SUPPL-6(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2013/04/19 |
SUPPL-5(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2012/08/13 |
SUPPL-4(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2011/08/22 |
SUPPL-3(补充) |
Approval |
REMS |
N/A
|
|
|
2011/01/25 |
SUPPL-2(补充) |
Approval |
REMS |
N/A
|
|
|
2011/01/25 |
SUPPL-1(补充) |
Approval |
Labeling |
STANDARD
|
|
|
2010/10/08 |
ORIG-1(原始申请) |
Approval |
Type 3 - New Dosage Form |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
与本品治疗等效的药品
活性成分:RISEDRONATE SODIUM 剂型/给药途径:TABLET, DELAYED RELEASE;ORAL 规格:35MG 治疗等效代码:AB
申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
022560 |
001 |
NDA |
ATELVIA |
RISEDRONATE SODIUM |
TABLET, DELAYED RELEASE;ORAL |
35MG |
Prescription |
Yes |
Yes |
AB |
2010/10/08
|
APIL |
203217 |
001 |
ANDA |
RISEDRONATE SODIUM |
RISEDRONATE SODIUM |
TABLET, DELAYED RELEASE;ORAL |
35MG |
Prescription |
No |
No |
AB |
2015/05/18
|
TEVA PHARMS USA |
203925 |
001 |
ANDA |
RISEDRONATE SODIUM |
RISEDRONATE SODIUM |
TABLET, DELAYED RELEASE;ORAL |
35MG |
Prescription |
No |
No |
AB |
2019/07/09
|
SUN PHARM |